文献速递妇科生殖医学

子宫动脉栓塞术后的生育临床研究

Clinical investigation of fertility after uterine artery embolization.
PubMed 文献 · Am J Obstet Gynecol · 2021-05-29

这项回顾性队列研究纳入398例43岁以下因症状性肌瘤和/或腺肌症接受子宫动脉栓塞术的患者,总体临床成功率为91.2%,无重大并发症;术后1年肌瘤体积平均缩小73%;共148次妊娠、109例活产,其中74例足月、23例早产(平均35.12±2.78周)。

要点

  • 子宫动脉栓塞术总体临床成功率91.2%,无重大并发症。
  • 术后1年肌瘤体积平均缩小73%。
  • 148次妊娠、109例活产,74例足月、23例早产。

核心结论

  • 研究提供了398例子宫动脉栓塞术患者详细的临床与产科结局,有助于识别影响术后生育的解剖与技术因素。

研究设计与样本

  • 回顾性队列研究,纳入2003至2017年间接受子宫动脉栓塞术的398例43岁以下症状性肌瘤和/或腺肌症患者。

主要发现

  • 总体临床成功率(经量过多、缺铁性贫血、盆腔压迫等症状缓解)为91.2%,无重大并发症。
  • 术后1年肌瘤体积平均缩小73%。
  • 108例(49.3%)存在危险子宫-卵巢吻合,33例(14.5%)接受了卵巢保护。
  • 共148次妊娠、109例活产;74例足月,23例早产,早产平均孕周35.12±2.78周。
  • 子宫解剖恢复和卵巢保护被确定为产科成功的主要预测因素;解剖恢复也与较低流产率相关。

临床怎么用

  • 对于不适合肌瘤剔除术且有生育意愿的育龄患者,子宫动脉栓塞术可作为保留生育功能的技术选择。
  • 术中应识别危险子宫-卵巢吻合并酌情行卵巢保护,以改善产科结局。

局限性

  • 为回顾性队列研究,需进一步对照临床试验确认结果并重新评估该手术对有生育意愿女性的适应证与局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Uterine artery embolization is an effective and safe technique for the treatment of uterine fibroids, but its use remains controversial for women who wish to procreate. OBJECTIVE: This study aimed to study the clinical, anatomic, and obstetrical results of uterine artery embolization in patients of childbearing age not eligible for myomectomy. STUDY DESIGN: This was a retrospective cohort study of 398 female patients under the age of 43 years who were treated by uterine artery embolization between 2003 and 2017 for symptomatic fibroids and/or adenomyosis. Uterine artery embolization was performed according to a standardized procedure (fertility-sparing uterine artery embolization technique), with ovarian protection in the event of dangerous utero-ovarian anastomosis. Magnetic resonance imaging and pelvic ultrasounds were performed before and after uterine artery embolization. RESULTS: The overall clinical success rate (ie, resolution of preembolization symptoms such as heavy menstrual bleeding, iron-deficiency anemia, pelvic pressure) was 91.2%, and there were no major complications. One year after uterine artery embolization, we observed a mean 73% reduction in myoma volume. A total of 108 patients (49.3%) presented with dangerous utero-ovarian anastomosis and 33 (14.5%) benefited from ovarian protection. In our group, there were 148 pregnancies and 109 live births; 74 children were born at term; 23 were born preterm, on average at 35.12±2.78 weeks. Including preterm births, the mean birthweight and birth length of the children were within normal limits. Restoration of uterine anatomy and ovarian protection were identified as the main predictive factors for obstetrical success. Restoration was also a major predictive factor for clinical success and was associated with a lower rate of miscarriage. CONCLUSION: This study provided detailed clinical and obstetrical outcomes for 398 female patients who underwent uterine artery embolization for fibroid treatment; it contributes to the identification of anatomic and technical factors that could have an impact on fertility after uterine artery embolization. Further controlled clinical trials are needed to confirm our findings and reevaluate this procedure's indications and limitations for women with a desire to procreate.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Serres-Cousine O, Kuijper FM, Curis E, et al. Clinical investigation of fertility after uterine artery embolization. Am J Obstet Gynecol. 2021. PMID: 34058169. doi:10.1016/j.ajog.2021.05.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。